- Home
- INTS vs HKIT Comparison
INTS vs HKIT Comparison
Compare INTS & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- HKIT
- Stock Information
- Founded
- INTS 2012
- HKIT 1996
- Country
- INTS United States
- HKIT China
- Employees
- INTS N/A
- HKIT N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- HKIT Computer Software: Prepackaged Software
- Sector
- INTS Health Care
- HKIT Technology
- Exchange
- INTS Nasdaq
- HKIT Nasdaq
- Market Cap
- INTS 30.8M
- HKIT 35.7M
- IPO Year
- INTS 2023
- HKIT 2023
- Fundamental
- Price
- INTS $1.30
- HKIT $1.25
- Analyst Decision
- INTS Strong Buy
- HKIT
- Analyst Count
- INTS 3
- HKIT 0
- Target Price
- INTS $8.50
- HKIT N/A
- AVG Volume (30 Days)
- INTS 37.8K
- HKIT 18.8K
- Earning Date
- INTS 05-08-2025
- HKIT 04-29-2025
- Dividend Yield
- INTS N/A
- HKIT N/A
- EPS Growth
- INTS N/A
- HKIT N/A
- EPS
- INTS N/A
- HKIT 0.04
- Revenue
- INTS N/A
- HKIT $3,449,206.00
- Revenue This Year
- INTS N/A
- HKIT N/A
- Revenue Next Year
- INTS N/A
- HKIT N/A
- P/E Ratio
- INTS N/A
- HKIT $33.40
- Revenue Growth
- INTS N/A
- HKIT N/A
- 52 Week Low
- INTS $1.27
- HKIT $1.01
- 52 Week High
- INTS $5.28
- HKIT $2.18
- Technical
- Relative Strength Index (RSI)
- INTS 22.77
- HKIT 51.73
- Support Level
- INTS $1.78
- HKIT $1.18
- Resistance Level
- INTS $1.94
- HKIT $1.27
- Average True Range (ATR)
- INTS 0.17
- HKIT 0.04
- MACD
- INTS -0.03
- HKIT 0.00
- Stochastic Oscillator
- INTS 4.10
- HKIT 51.11
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.